摘要
目的探讨xelox与sox方案对胃癌术后患者的近期疗效和副作用。方法选取我院2014年1月~2020年4月收治的胃癌患者96例,按治疗方案的不同分为A组(42例)和B组(54例)。A组采用奥沙利铂+卡培他滨方案治疗,B组采用奥沙利铂+替吉奥方案治疗,每3周为1周期,共治疗6个周期,比较两组近期疗效及副作用。结果A组34例无复发肿瘤,14例患者发生呕吐;B组44例无复发肿瘤,8例患者发生呕吐,两组之间其他副作用均无统计学意义(p﹥0.05)。结论两种方案在治疗胃癌术后患者中的近期疗效相仿,副作用轻,耐受性好.。
Objective:To investigate the short-term clinical effect and toxicity of XELOX and SOX regimen in the treatment of gastric cancer.Methods:Totally,96 patients with gastric cancer were admitted and treated in our hospital from January 2014 to April 2020.They were divided into A group(n=42)and B group(n=54).Patients in A group were treated with oxaliplatin combined with capecitabine,while patients in B group were treated with oxaliplatin combined with Tegio.After 18 weeks,the short-term clinical effect and toxicity were compared between the two groups.Results:During follow-up 34 patients had no recurrence of the gastric cancer,and 14 patients caused vomiting in A group.In addition,44 patients had no recurrence of the gastric cancer,and 8 patients caused vomiting in B group.There was no difference in other side effects in the two groups(p﹥0.05).Conclusions:XELOX regimen and SOX regimen are similar in curative effect on account of with mild side effects and well tolerability.
作者
童刚
泽永革
徐子寓
Tong Gang;Yongge Ze;Ziyu Xu(Tibet University Medical School,Lhasa,Tibet 850000,China)
出处
《西藏医药》
2020年第6期17-19,共3页
Tibetan Medicine
基金
西藏大学医学院研究生“高水平人才培养计划”项目,项目编号:2019YXYYJS026。
关键词
XELOX
SOX
胃癌
辅助化疗
XELOX Regimen
SOX Regimen
Gastric Cancer
Adjuvant Chemotherapy
